Liposomal targeting of angiogenic vasculature

Active targeting of angiogenic vasculature represents a promising therapeutic strategy to fight a variety of diseases. In particular, attention has been focused on inhibition of tumor growth. In this review, the recent progress in targeting liposomes to angiogenic endothelial cells is discussed.

Saved in:
Bibliographic Details
Published inCurrent drug delivery Vol. 2; no. 4; p. 363
Main Authors Schiffelers, Raymond M, Fens, Marcel H A M, Janssen, Adriënne P C A, Molema, Grietje, Storm, Gert
Format Journal Article
LanguageEnglish
Published United Arab Emirates 01.10.2005
Subjects
Angiogenesis Inhibitors - administration & dosage
Angiogenesis Inhibitors - therapeutic use
Animals
Drug Carriers
Humans
Liposomes
Neoplasms - pathology
Neovascularization, Pathologic - drug therapy
Neovascularization, Pathologic - pathology
Online AccessGet more information

Cover

More Information
Summary:Active targeting of angiogenic vasculature represents a promising therapeutic strategy to fight a variety of diseases. In particular, attention has been focused on inhibition of tumor growth. In this review, the recent progress in targeting liposomes to angiogenic endothelial cells is discussed.
ISSN:1567-2018
DOI:10.2174/156720105774370186